Michal Reid, M.D.

Professional Background

Dr. Michal Reid is an Assistant Professor in the Division of Pulmonary, Critical Care, and Sleep Medicine at the University of Kansas Medical Center. Dr. Reid received his MD at Jagiellonian University (UJ) Medical College, School of Medicine in Krakow, Poland. He completed his Internal Medicine Residency training at Cleveland Clinic, his Pulmonary and Critical Care Fellowship training at Loyola University Medical Center, and also completed additional training in Interventional and Advanced Diagnostic Pulmonology at the Mayo Clinic.

Dr. Reid specializes in minimally invasive diagnostic and therapeutic procedures of the respiratory system including endobronchial ultrasound, robotic bronchoscopy, rigid bronchoscopy, airway stents, endobronchial valves, bronchoscopic lung volume reduction, medical pleuroscopy, and tunneled pleural catheter placement.

His clinical interests include lung cancer diagnosis, staging and palliation, pulmonary nodules, malignant and benign central airway disease, complex pleural disease, and chronic obstructive lung disease.

Dr Reid also attends in the medical intensive care unit where he works with a multidisciplinary team to provide care for critically ill patients. In addition to his clinical practice, his research interests include early detection of lung cancer, lung cancer screening, complex pleural disease, and central airway obstruction.

Dr. Reid is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology. His professional affiliations include memberships in the American College of Chest Physicians, the American Thoracic Society, American Association for Bronchology and Interventional Pulmonology, and International Association for the Study of Lung Cancer.

• BA, History, Concordia University, Montreal, Quebec
• MD, Doctor of Medicine, Jagiellonian University (UJ) Medical College, School of Medicine in English, Krakow, Poland
• Residency, Internal Medicine, Cleveland Clinic, Cleveland, Ohio
• Clinical Fellowship, Pulmonary and Critical Care, Loyola University Medical Center (LUMC), Maywood, Illinois
• Clinical Fellowship, Interventional and Advanced Diagnostic Pulmonology, Mayo Clinic, Rochester, Minnesota

• Board Certified in Internal Medicine, American Board of Internal Medicine
• Board Certified in Pulmonary Disease, American Board of Internal Medicine

---

• Andrychiewicz, A , Gorka, K, Reid, M, Soja, J, Sladek, K, Szczeklik, W. 2015. Modern methods for the endoscopic treatment of obstructive pulmonary diseases. Journal of Asthma, 52 (9), 1-19
• Soja, J, Łoboda, P, Mikrut, S, Ćmiel, A, Gross-Sondej, I, Górka, K, Kasper, Ł, Andrychiewicz, A, Pulka, G, Reid, M, Sładek, K. 2015. Assessment of remodeling in chronic obstructive pulmonary disease using imaging methods. Polskie Archiwum Medycyny Wewnetrznej, 659-665
• Morgan, L, Choi, H, Reid, M, Khawaja, A, Mazzone , P. 2017. The frequency of incidental findings and subsequent testing in low-dose CT scans for lung cancer screening. Annals of the American Thoracic Society, 14 (9), 1450-1456
• Reid, M, Choi, H, Han, X, Wang, X, Mukhopadhyay, S, Kou, L, Ahmad, U, Wang, X, Mazzone, P. 2019. Development of a risk prediction model to estimate the probability of malignancy in pulmonary nodules being considered for biopsy. Chest, 156 (2), 367-375
• Reid, M, Reisenauer, C, Wigle, D, Reisenauer, J. 2021. Investigation and Management of Massive Hemoptysis. American Board of Thoracic Surgery
• Warrior, K, Chung, PA, Reid, M, Bemiss, BC. 2021. Use of Nintedanib and Pirfenidone in Non-Idiopathic Pulmonary Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine, 204 (1), 92-94
• Bhardwaj , S, Chung, PA, Nigdelioglu , R, Reid, M, Lockhart, M, Forsythe, SM, Ananthanarayanan, V. 2022. Impacted gutkha presenting as an intrabronchial mass lesion leading to post-obstructive pneumonia. Respiratory Medicine Case Reports, 37